The market is mainly driven by the significant applications of Monoclonal Antibody Therapeutics in various end use industries. The expanding demands from the Cancer, Autoimmune Diseases, Infection and Hematological Diseases, are propelling Monoclonal Antibody Therapeutics market. Humanized Antibody, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Human Mouse Chimeric Antibody segment is estimated at % CAGR for the next seven-year period.

Asia Pacific shows high growth potential for Monoclonal Antibody Therapeutics market, driven by demand from China, the second largest economy with some signs of stabilising, the Monoclonal Antibody Therapeutics market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Monoclonal Antibody Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Monoclonal Antibody Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Monoclonal Antibody Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Monoclonal Antibody Therapeutics sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Monoclonal Antibody Therapeutics covered in this report include Bayer, F. Hoffmann-La Roche, Pfizer, Sanofi, GlaxoSmithKline, Merck, Novartis, AbbVie and Amgen, etc.

The global Monoclonal Antibody Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Bayer

F. Hoffmann-La Roche

Pfizer

Sanofi

GlaxoSmithKline

Merck

Novartis

AbbVie

Amgen

Johnson & Johnson

Bristol-Myers Squibb Company

Biogen

Scope of Monoclonal Antibody Therapeutics - Market Report

Report Metric	Details
Report Name	Monoclonal Antibody Therapeutics - Market
Forecasted market size in 2029	US$ 190750 million
CAGR	7.1%
Forecasted years	2023 - 2029
Global Monoclonal Antibody Therapeutics market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Monoclonal Antibody Therapeutics market, Segment by Type:	Humanized Antibody Human Mouse Chimeric Antibody
Global Monoclonal Antibody Therapeutics market, by Application	Cancer Autoimmune Diseases Infection Hematological Diseases Ophthalmological Diseases Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Monoclonal Antibody Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Monoclonal Antibody Therapeutics - Market size in 2029?

Ans: The Monoclonal Antibody Therapeutics - Market size in 2029 will be US$ 190750 million.

What are the Application segmentation covered in the Monoclonal Antibody Therapeutics - Market report?

Ans: The Applications covered in the Monoclonal Antibody Therapeutics - Market report are Cancer, Autoimmune Diseases, Infection, Hematological Diseases, Ophthalmological Diseases, Others

What are the Type segmentation covered in the Monoclonal Antibody Therapeutics - Market report?

Ans: The Types covered in the Monoclonal Antibody Therapeutics - Market report are Humanized Antibody, Human Mouse Chimeric Antibody

1 Market Overview of Monoclonal Antibody Therapeutics

1.1 Monoclonal Antibody Therapeutics Market Overview

1.1.1 Monoclonal Antibody Therapeutics Product Scope

1.1.2 Monoclonal Antibody Therapeutics Market Status and Outlook

1.2 Global Monoclonal Antibody Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Monoclonal Antibody Therapeutics Market Size by Region (2018-2029)

1.4 Global Monoclonal Antibody Therapeutics Historic Market Size by Region (2018-2023)

1.5 Global Monoclonal Antibody Therapeutics Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Monoclonal Antibody Therapeutics Market Size (2018-2029)

1.6.1 North America Monoclonal Antibody Therapeutics Market Size (2018-2029)

1.6.2 Europe Monoclonal Antibody Therapeutics Market Size (2018-2029)

1.6.3 Asia-Pacific Monoclonal Antibody Therapeutics Market Size (2018-2029)

1.6.4 Latin America Monoclonal Antibody Therapeutics Market Size (2018-2029)

1.6.5 Middle East & Africa Monoclonal Antibody Therapeutics Market Size (2018-2029)

2 Monoclonal Antibody Therapeutics Market by Type

2.1 Introduction

2.1.1 Humanized Antibody

2.1.2 Human Mouse Chimeric Antibody

2.2 Global Monoclonal Antibody Therapeutics Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Type (2018-2023)

2.2.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Monoclonal Antibody Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Monoclonal Antibody Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Monoclonal Antibody Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Monoclonal Antibody Therapeutics Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Monoclonal Antibody Therapeutics Revenue Breakdown by Type (2018-2029)

3 Monoclonal Antibody Therapeutics Market Overview by Application

3.1 Introduction

3.1.1 Cancer

3.1.2 Autoimmune Diseases

3.1.3 Infection

3.1.4 Hematological Diseases

3.1.5 Ophthalmological Diseases

3.1.6 Others

3.2 Global Monoclonal Antibody Therapeutics Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Monoclonal Antibody Therapeutics Historic Market Size by Application (2018-2023)

3.2.2 Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Monoclonal Antibody Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Monoclonal Antibody Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Monoclonal Antibody Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Monoclonal Antibody Therapeutics Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Monoclonal Antibody Therapeutics Revenue Breakdown by Application (2018-2029)

4 Monoclonal Antibody Therapeutics Competition Analysis by Players

4.1 Global Monoclonal Antibody Therapeutics Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monoclonal Antibody Therapeutics as of 2022)

4.3 Date of Key Players Enter into Monoclonal Antibody Therapeutics Market

4.4 Global Top Players Monoclonal Antibody Therapeutics Headquarters and Area Served

4.5 Key Players Monoclonal Antibody Therapeutics Product Solution and Service

4.6 Competitive Status

4.6.1 Monoclonal Antibody Therapeutics Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Bayer

5.1.1 Bayer Profile

5.1.2 Bayer Main Business

5.1.3 Bayer Monoclonal Antibody Therapeutics Products, Services and Solutions

5.1.4 Bayer Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)

5.1.5 Bayer Recent Developments

5.2 F. Hoffmann-La Roche

5.2.1 F. Hoffmann-La Roche Profile

5.2.2 F. Hoffmann-La Roche Main Business

5.2.3 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Products, Services and Solutions

5.2.4 F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)

5.2.5 F. Hoffmann-La Roche Recent Developments

5.3 Pfizer

5.3.1 Pfizer Profile

5.3.2 Pfizer Main Business

5.3.3 Pfizer Monoclonal Antibody Therapeutics Products, Services and Solutions

5.3.4 Pfizer Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)

5.3.5 Sanofi Recent Developments

5.4 Sanofi

5.4.1 Sanofi Profile

5.4.2 Sanofi Main Business

5.4.3 Sanofi Monoclonal Antibody Therapeutics Products, Services and Solutions

5.4.4 Sanofi Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)

5.4.5 Sanofi Recent Developments

5.5 GlaxoSmithKline

5.5.1 GlaxoSmithKline Profile

5.5.2 GlaxoSmithKline Main Business

5.5.3 GlaxoSmithKline Monoclonal Antibody Therapeutics Products, Services and Solutions

5.5.4 GlaxoSmithKline Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)

5.5.5 GlaxoSmithKline Recent Developments

5.6 Merck

5.6.1 Merck Profile

5.6.2 Merck Main Business

5.6.3 Merck Monoclonal Antibody Therapeutics Products, Services and Solutions

5.6.4 Merck Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)

5.6.5 Merck Recent Developments

5.7 Novartis

5.7.1 Novartis Profile

5.7.2 Novartis Main Business

5.7.3 Novartis Monoclonal Antibody Therapeutics Products, Services and Solutions

5.7.4 Novartis Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)

5.7.5 Novartis Recent Developments

5.8 AbbVie

5.8.1 AbbVie Profile

5.8.2 AbbVie Main Business

5.8.3 AbbVie Monoclonal Antibody Therapeutics Products, Services and Solutions

5.8.4 AbbVie Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)

5.8.5 AbbVie Recent Developments

5.9 Amgen

5.9.1 Amgen Profile

5.9.2 Amgen Main Business

5.9.3 Amgen Monoclonal Antibody Therapeutics Products, Services and Solutions

5.9.4 Amgen Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)

5.9.5 Amgen Recent Developments

5.10 Johnson & Johnson

5.10.1 Johnson & Johnson Profile

5.10.2 Johnson & Johnson Main Business

5.10.3 Johnson & Johnson Monoclonal Antibody Therapeutics Products, Services and Solutions

5.10.4 Johnson & Johnson Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)

5.10.5 Johnson & Johnson Recent Developments

5.11 Bristol-Myers Squibb Company

5.11.1 Bristol-Myers Squibb Company Profile

5.11.2 Bristol-Myers Squibb Company Main Business

5.11.3 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Products, Services and Solutions

5.11.4 Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)

5.11.5 Bristol-Myers Squibb Company Recent Developments

5.12 Biogen

5.12.1 Biogen Profile

5.12.2 Biogen Main Business

5.12.3 Biogen Monoclonal Antibody Therapeutics Products, Services and Solutions

5.12.4 Biogen Monoclonal Antibody Therapeutics Revenue (US$ Million) & (2018-2023)

5.12.5 Biogen Recent Developments

6 North America

6.1 North America Monoclonal Antibody Therapeutics Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Monoclonal Antibody Therapeutics Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Monoclonal Antibody Therapeutics Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Monoclonal Antibody Therapeutics Market Dynamics

11.1 Monoclonal Antibody Therapeutics Industry Trends

11.2 Monoclonal Antibody Therapeutics Market Drivers

11.3 Monoclonal Antibody Therapeutics Market Challenges

11.4 Monoclonal Antibody Therapeutics Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Bristol Myers Squibb Company

Biogen

List of Tables

Table 1. Global Market Monoclonal Antibody Therapeutics Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Monoclonal Antibody Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Monoclonal Antibody Therapeutics Market Size Share by Region (2018-2023)

Table 4. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Monoclonal Antibody Therapeutics Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Monoclonal Antibody Therapeutics Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Monoclonal Antibody Therapeutics Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2018-2023)

Table 9. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Monoclonal Antibody Therapeutics Revenue Market Share by Type (2024-2029)

Table 11. North America Monoclonal Antibody Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Monoclonal Antibody Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Monoclonal Antibody Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Monoclonal Antibody Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Monoclonal Antibody Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Monoclonal Antibody Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Monoclonal Antibody Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Monoclonal Antibody Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Monoclonal Antibody Therapeutics Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Monoclonal Antibody Therapeutics Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Monoclonal Antibody Therapeutics Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Monoclonal Antibody Therapeutics Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Monoclonal Antibody Therapeutics Revenue Market Share by Application (2018-2023)

Table 24. Global Monoclonal Antibody Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Monoclonal Antibody Therapeutics Revenue Market Share by Application (2024-2029)

Table 26. North America Monoclonal Antibody Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Monoclonal Antibody Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Monoclonal Antibody Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Monoclonal Antibody Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Monoclonal Antibody Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Monoclonal Antibody Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Monoclonal Antibody Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Monoclonal Antibody Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Monoclonal Antibody Therapeutics Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Monoclonal Antibody Therapeutics Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Monoclonal Antibody Therapeutics Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Monoclonal Antibody Therapeutics Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Monoclonal Antibody Therapeutics as of 2022)

Table 39. Date of Key Players Enter into Monoclonal Antibody Therapeutics Market

Table 40. Global Monoclonal Antibody Therapeutics Key Players Headquarters and Area Served

Table 41. Monoclonal Antibody Therapeutics Product Solution and Service

Table 42. Global Monoclonal Antibody Therapeutics Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Bayer Basic Information List

Table 45. Bayer Description and Business Overview

Table 46. Bayer Monoclonal Antibody Therapeutics Products, Services and Solutions

Table 47. Revenue (US$ Million) in Monoclonal Antibody Therapeutics Business of Bayer (2018-2023)

Table 48. Bayer Recent Developments

Table 49. F. Hoffmann-La Roche Basic Information List

Table 50. F. Hoffmann-La Roche Description and Business Overview

Table 51. F. Hoffmann-La Roche Monoclonal Antibody Therapeutics Products, Services and Solutions

Table 52. Revenue (US$ Million) in Monoclonal Antibody Therapeutics Business of F. Hoffmann-La Roche (2018-2023)

Table 53. F. Hoffmann-La Roche Recent Developments

Table 54. Pfizer Basic Information List

Table 55. Pfizer Description and Business Overview

Table 56. Pfizer Monoclonal Antibody Therapeutics Products, Services and Solutions

Table 57. Revenue (US$ Million) in Monoclonal Antibody Therapeutics Business of Pfizer (2018-2023)

Table 58. Pfizer Recent Developments

Table 59. Sanofi Basic Information List

Table 60. Sanofi Description and Business Overview

Table 61. Sanofi Monoclonal Antibody Therapeutics Products, Services and Solutions

Table 62. Revenue (US$ Million) in Monoclonal Antibody Therapeutics Business of Sanofi (2018-2023)

Table 63. Sanofi Recent Developments

Table 64. GlaxoSmithKline Basic Information List

Table 65. GlaxoSmithKline Description and Business Overview

Table 66. GlaxoSmithKline Monoclonal Antibody Therapeutics Products, Services and Solutions

Table 67. Revenue (US$ Million) in Monoclonal Antibody Therapeutics Business of GlaxoSmithKline (2018-2023)

Table 68. GlaxoSmithKline Recent Developments

Table 69. Merck Basic Information List

Table 70. Merck Description and Business Overview

Table 71. Merck Monoclonal Antibody Therapeutics Products, Services and Solutions

Table 72. Revenue (US$ Million) in Monoclonal Antibody Therapeutics Business of Merck (2018-2023)

Table 73. Merck Recent Developments

Table 74. Novartis Basic Information List

Table 75. Novartis Description and Business Overview

Table 76. Novartis Monoclonal Antibody Therapeutics Products, Services and Solutions

Table 77. Revenue (US$ Million) in Monoclonal Antibody Therapeutics Business of Novartis (2018-2023)

Table 78. Novartis Recent Developments

Table 79. AbbVie Basic Information List

Table 80. AbbVie Description and Business Overview

Table 81. AbbVie Monoclonal Antibody Therapeutics Products, Services and Solutions

Table 82. Revenue (US$ Million) in Monoclonal Antibody Therapeutics Business of AbbVie (2018-2023)

Table 83. AbbVie Recent Developments

Table 84. Amgen Basic Information List

Table 85. Amgen Description and Business Overview

Table 86. Amgen Monoclonal Antibody Therapeutics Products, Services and Solutions

Table 87. Revenue (US$ Million) in Monoclonal Antibody Therapeutics Business of Amgen (2018-2023)

Table 88. Amgen Recent Developments

Table 89. Johnson & Johnson Basic Information List

Table 90. Johnson & Johnson Description and Business Overview

Table 91. Johnson & Johnson Monoclonal Antibody Therapeutics Products, Services and Solutions

Table 92. Revenue (US$ Million) in Monoclonal Antibody Therapeutics Business of Johnson & Johnson (2018-2023)

Table 93. Johnson & Johnson Recent Developments

Table 94. Bristol-Myers Squibb Company Basic Information List

Table 95. Bristol-Myers Squibb Company Description and Business Overview

Table 96. Bristol-Myers Squibb Company Monoclonal Antibody Therapeutics Products, Services and Solutions

Table 97. Revenue (US$ Million) in Monoclonal Antibody Therapeutics Business of Bristol-Myers Squibb Company (2018-2023)

Table 98. Bristol-Myers Squibb Company Recent Developments

Table 99. Biogen Basic Information List

Table 100. Biogen Description and Business Overview

Table 101. Biogen Monoclonal Antibody Therapeutics Products, Services and Solutions

Table 102. Revenue (US$ Million) in Monoclonal Antibody Therapeutics Business of Biogen (2018-2023)

Table 103. Biogen Recent Developments

Table 104. North America Monoclonal Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 105. North America Monoclonal Antibody Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 106. Europe Monoclonal Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 107. Europe Monoclonal Antibody Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 108. Asia-Pacific Monoclonal Antibody Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 109. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2018-2023) & (US$ Million)

Table 110. Asia-Pacific Monoclonal Antibody Therapeutics Market Size by Region (2024-2029) & (US$ Million)

Table 111. Asia-Pacific Monoclonal Antibody Therapeutics Market Share by Region (2018-2023)

Table 112. Asia-Pacific Monoclonal Antibody Therapeutics Market Share by Region (2024-2029)

Table 113. Latin America Monoclonal Antibody Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 114. Latin America Monoclonal Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 115. Latin America Monoclonal Antibody Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 116. Middle East & Africa Monoclonal Antibody Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 117. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2018-2023) & (US$ Million)

Table 118. Middle East & Africa Monoclonal Antibody Therapeutics Market Size by Country (2024-2029) & (US$ Million)

Table 119. Monoclonal Antibody Therapeutics Market Trends

Table 120. Monoclonal Antibody Therapeutics Market Drivers

Table 121. Monoclonal Antibody Therapeutics Market Challenges

Table 122. Monoclonal Antibody Therapeutics Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Monoclonal Antibody Therapeutics Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Monoclonal Antibody Therapeutics Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Monoclonal Antibody Therapeutics Market Share by Regions: 2022 VS 2029

Figure 4. Global Monoclonal Antibody Therapeutics Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Monoclonal Antibody Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Monoclonal Antibody Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Monoclonal Antibody Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Monoclonal Antibody Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Monoclonal Antibody Therapeutics Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Humanized Antibody

Figure 11. Global Humanized Antibody Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Human Mouse Chimeric Antibody

Figure 13. Global Human Mouse Chimeric Antibody Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Global Monoclonal Antibody Therapeutics Market Size Share by Type: 2022 & 2029

Figure 15. North America Monoclonal Antibody Therapeutics Revenue Market Share by Type (2018-2029)

Figure 16. Europe Monoclonal Antibody Therapeutics Revenue Market Share by Type (2018-2029)

Figure 17. Asia-Pacific Monoclonal Antibody Therapeutics Revenue Market Share by Type (2018-2029)

Figure 18. Latin America Monoclonal Antibody Therapeutics Revenue Market Share by Type (2018-2029)

Figure 19. Middle East and Africa Monoclonal Antibody Therapeutics Revenue Market Share by Type (2018-2029)

Figure 20. Cancer Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 21. Autoimmune Diseases Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 22. Infection Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 23. Hematological Diseases Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 24. Ophthalmological Diseases Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 25. Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 26. Global Monoclonal Antibody Therapeutics Market Size Share by Application: 2022 & 2029

Figure 27. North America Monoclonal Antibody Therapeutics Revenue Market Share by Application (2018-2029)

Figure 28. Europe Monoclonal Antibody Therapeutics Revenue Market Share by Application (2018-2029)

Figure 29. Asia-Pacific Monoclonal Antibody Therapeutics Revenue Market Share by Application (2018-2029)

Figure 30. Latin America Monoclonal Antibody Therapeutics Revenue Market Share by Application (2018-2029)

Figure 31. Middle East and Africa Monoclonal Antibody Therapeutics Revenue Market Share by Application (2018-2029)

Figure 32. Monoclonal Antibody Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 33. Global Top 5 and Top 10 Players Monoclonal Antibody Therapeutics Market Share in 2022

Figure 34. North America Monoclonal Antibody Therapeutics Market Share by Country (2018-2029)

Figure 35. U.S. Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 36. Canada Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 37. Germany Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 38. France Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 39. U.K. Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 40. Italy Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 41. Russia Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 42. Nordic Countries Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 43. Asia-Pacific Monoclonal Antibody Therapeutics Market Share by Region (2018-2029)

Figure 44. China Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 45. Japan Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 46. South Korea Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 47. Southeast Asia Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 48. India Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 49. Australia Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 50. Latin America Monoclonal Antibody Therapeutics Market Share by Country (2018-2029)

Figure 51. Mexico Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 52. Brazil Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 53. Middle East & Africa Monoclonal Antibody Therapeutics Market Share by Country (2018-2029)

Figure 54. Turkey Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 55. Saudi Arabia Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 56. UAE Monoclonal Antibody Therapeutics Market Size (2018-2029) & (US$ Million)

Figure 57. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Substrate Cutting Device Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-23Z18292

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Targeted Radionuclide Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-14Z15017

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Global Microfluidic Single-Cell Analysis and Screening System Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-7M18883

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

Medicinal Liquid Filling Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-37J14968

Thu Dec 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions